Since PLAs have not been assessed in cancer patients, we assessed several leukocyte populations for interaction with platelets: total leukocytes, neutrophils, monocytes, natural killer cells, T cells (CD4+ and CD8+), and B cells. This evidence concerns the gene CD4 and cancer.